Skip to Content

Notice

Manufacturer of Controlled Substances, Notice of Registration; Noramco Inc. (GA)

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

By Notice dated November 21, 2011, and published in the Federal Register on November 29, 2011, 76 FR 73679, Noramco Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

DrugSchedule
Codeine-N-oxide (9053)I
Dihydromorphine (9145)I
Morphine-N-oxide (9307)I
Amphetamine (1100)II
Methylphenidate (1724)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Hydrocodone (9193)II
Morphine (9300)II
Oripavine (9330)II
Thebaine (9333)II
Oxymorphone (9652)II
Noroxymorphone (9668)II
Alfentanil (9737)II
Sufentanil (9740)II
Carfentanil (9743)II
Tapentadol (9780)II
Fentanyl (9801)II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Noramco Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Noramco Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: March 8, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2012-6698 Filed 3-19-12; 8:45 am]

BILLING CODE 4410-09-P